Top 5 Stocks To Own
Strong oil prices are paving the way for some outstanding buying opportunities, says Young Capital Management Portfolio Manager Josh Young in this exclusive interview with The Energy Report. He points to four of his favorite undervalued plays, which may not stay below the radar long. Top 5 Stocks To Own:O’Charley’s Inc. (CHUX) O?Charley?s Inc. operates [...]
Now the world will get to see Groupon's eccentric CEO
In 2006, Andrew Mason got frustrated with the cancellation of his cell phone contract. He thought, “Perhaps I can create a website that allows for groups of people to protest things.” It was an enlightening idea, but Mason soon found out it was a money loser. So, he came up with a twist: Why not [...]
WGL Holdings Beats on EPS but GAAP Results Lag
WGL Holdings (NYSE: WGL ) reported earnings on Feb. 3. Here are the numbers you need to know. The 10-second takeawayFor the quarter ended Dec. 31 (Q1), WGL Holdings whiffed on revenues and beat expectations on earnings per share. Compared to the prior-year quarter, revenue dropped and GAAP earnings per share dropped significantly. Margins contracted across [...]
CEF Weekly Review – Back To The Start
Actionable Items: Highest Positive Spread: BlackRock Floating Rate Income Trust (BGT) Lowest Negative Spread: Gabelli Global Utility & Income Fund (GLU) Focus Stock of the Week: Gabelli Global Utility & Income Fund (GLU) Last Week’s Focus Stock: The Thai Capital Fund (TF) CEF Weekly Review: On average, the 13 closed-end fund (CEF) types registered a [...]
For Sale, Just Not at That Price
Scratch the “or best offer” from Human Genome Sciences’ (Nasdaq: HGSI ) For Sale sign. The biotech is willing to be taken out, just not at the price GlaxoSmithKline (NYSE: GSK ) is willing to pay. Human Genome Sciences is partnered with Glaxo on their lupus drug Benlysta and has licensed a few other drugs to the [...]
